Rottendorf Pharma GmbH has continued its global expansion with the addition of offices in Chicago and the establishment of the Rottendorf Pharma, Inc. subsidiary. Gordon Haines has been appointed chief executive officer of Rottendorf Pharma. Inc., which will initially focus its efforts on developing markets through business development and supply chain activities in the U.S. Manufacturing operations in Germany and Europe will initially support these efforts, with plans for a U.S.-based packaging...